Vinciguerra M, Passarello C, Cassarà F, Leto F, Cannata M, Calvaruso G, Di Maggio R, Renda D, Maggio A, Giambona A
Department of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies, Villa Sofia-Cervello Hospital, Palermo, Italy.
Int J Lab Hematol. 2016 Feb;38(1):17-26. doi: 10.1111/ijlh.12433. Epub 2015 Sep 29.
During an intensive screening program aimed at identifying the healthy carriers of thalassemia and the couples at risk of bearing an affected fetus, a rare single nucleotide variation (SNV), CAP + 1570 T > C (HBB:c*96T > C), located 12 nucleotides upstream of the polyadenylation signal in 3'UTR of the beta globin gene was identified. It was previously reported as a β+ thalassemia mutation and later as a plain polymorphism.
Genotype identification of globin gene mutations was carried out using sequencing analysis, GAP-PCR, and MLPA methods.
CAP + 1570 T > C (HBB:c*96T > C) was found in 39 heterozygotes, in one case in homozygous state and in thirteen cases of co-inheritance of this nucleotide substitution with other mutations in globin genes. Carriers of this mutation showed a 'silent' phenotype without appreciable microcytosis and hypochromia, so they cannot be differentiated from noncarrier individuals. Compound heterozygotes for this mutation and severe β-thal mutations showed a variable phenotype ranging from β-thal carrier to mild form of β-thalassemia intermedia, revealing new aspects and allowing to better understand the clinical implications of this nucleotide substitution that can be classified as a silent β-thalassemic defect.
Data reported in this study indicate the need of investigating partner of β-thalassemia carrier by complete sequencing analysis of β-globin gene and of providing an appropriate genetic counseling for couples at risk undergoing prenatal diagnosis.
在一项旨在识别地中海贫血健康携带者以及有生育受影响胎儿风险的夫妇的强化筛查项目中,在β珠蛋白基因3'UTR多聚腺苷酸化信号上游12个核苷酸处发现了一种罕见的单核苷酸变异(SNV),即CAP + 1570 T > C(HBB:c*96T > C)。该变异先前被报道为β+地中海贫血突变,后来又被报道为单纯多态性。
采用测序分析、间隙聚合酶链反应(GAP-PCR)和多重连接探针扩增(MLPA)方法进行珠蛋白基因突变的基因型鉴定。
发现39例杂合子携带CAP + 1570 T > C(HBB:c*96T > C),1例为纯合状态,13例该核苷酸替代与珠蛋白基因的其他突变共同遗传。该突变携带者表现出“沉默”表型,无明显的小红细胞症和低色素血症,因此无法与非携带者个体区分开来。该突变与严重β地中海贫血突变的复合杂合子表现出从β地中海贫血携带者到中间型β地中海贫血轻度形式的可变表型,揭示了新的方面,并有助于更好地理解这种可归类为沉默β地中海贫血缺陷的核苷酸替代的临床意义。
本研究报告的数据表明,需要通过对β珠蛋白基因进行完整测序分析来调查β地中海贫血携带者的配偶,并为接受产前诊断的风险夫妇提供适当的遗传咨询。